Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Catheter Precision, Inc. on March 12, 2025. The registrant is incorporated in Delaware and maintains its principal executive offices in Fort Mill, South Carolina. The company's common stock trades on the NYSE American under the symbol VTAK.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure vehicle for an attached presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The report primarily functions to disclose the release of an investor presentation.
Guidance, Outlook, and Management Commentary
Under Item 7.01 (Regulation FD Disclosure), the company has attached an Investor Presentation dated March 2025 as Exhibit 99.1. This presentation is incorporated by reference and likely contains management commentary, outlook, and strategic updates, though the specific content is not summarized in the filing text itself.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Investor Presentation Dated March 2025) for detailed financial guidance and strategic updates.
- Verify the trading status of common stock (VTAK) on the NYSE American.
- Note that this filing does not contain audited financial data or specific quarterly results.